Literature DB >> 368657

A high molecular weight form of terminal deoxynucleotidyl transferase.

F J Bollum, M Brown.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 368657     DOI: 10.1038/278191a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

1.  Antibody repertoire development in fetal and neonatal piglets. XXII. λ Rearrangement precedes κ rearrangement during B-cell lymphogenesis in swine.

Authors:  Xiuzhu Sun; Nancy Wertz; Kelly Lager; Marek Sinkora; Katerina Stepanova; Gregory Tobin; John E Butler
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

2.  Cloning of terminal transferase cDNA by antibody screening.

Authors:  N R Landau; T P St John; I L Weissman; S C Wolf; A E Silverstone; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  Terminal deoxynucleotidyltransferase. Alignment of alpha- and beta-subunits of the core enzyme along the primary translation product.

Authors:  C M Beach; S K Chan; T C Vanaman; M S Coleman
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

4.  Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector.

Authors:  N R Landau; D G Schatz; M Rosa; D Baltimore
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

5.  Elimination of nonspecific bands in non-radioactive electrophoretic mobility shift assays using the digoxigenin system.

Authors:  Saimi Tokunaga; John J Stegeman
Journal:  Anal Biochem       Date:  2014-07-05       Impact factor: 3.365

6.  Terminal deoxynucleotidyl transferase expression in a Thy-l alloantigen variant lymphoma cell line.

Authors:  T F Bumol; E F Retzel; S D Douglas; R S Basch; J N Buxbaum; A J Faras
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

7.  Biochemical and immunological properties of human terminal deoxynucleotidyl transferase purified from blasts of acute lymphoblastic and chronic myelogenous leukemia.

Authors:  M R Deibel; M S Coleman; K Acree; J J Hutton
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

8.  The long isoform of terminal deoxynucleotidyl transferase enters the nucleus and, rather than catalyzing nontemplated nucleotide addition, modulates the catalytic activity of the short isoform.

Authors:  C L Benedict; S Gilfillan; J F Kearney
Journal:  J Exp Med       Date:  2001-01-01       Impact factor: 14.307

9.  The two isoforms of mouse terminal deoxynucleotidyl transferase differ in both the ability to add N regions and subcellular localization.

Authors:  L A Bentolila; M Fanton d'Andon; Q T Nguyen; O Martinez; F Rougeon; N Doyen
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

10.  Terminal deoxynucleotidyl transferase in human lymphomas: possible existence of forms with high and low molecular weights.

Authors:  P Vezzoni; F Campagnari; G Di Fronzo; L Clerici
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.